TickerFactsScreenerDevelopers

Emergent BioSolutions Inc. (EBS) — Revenue

Annual figures by fiscal year, from SEC filings.

2010: $286.17M2011: $273.38M2012: $281.89M2013: $312.75M2014: $450.14M2015: $522.79M2019: $1.11B2020: $1.58B2021: $1.77B2022: $1.12B2023: $1.05B2024: $1.04B2025: $742.90M$742.90M
2010Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$742.90M-28.8%
2024$1.04B-0.5%
2023$1.05B-6.1%
2022$1.12B-37.0%
2021$1.77B+12.4%
2020$1.58B+42.6%
2019$1.11B—
2015$522.79M+16.1%
2014$450.14M+43.9%
2013$312.75M+10.9%
2012$281.89M+3.1%
2011$273.38M-4.5%
2010$286.17M—